APA

Bar-Meir S., Chowers Y., Lavy A., Abramovitch D., Sternberg A., Leichtmann G., Reshef R., Odes S., Moshkovitz M., Bruck R., Eliakim R., Maoz E. & Mittmann U. (19981022). Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group. : Gastroenterology.

Chicago

Bar-Meir S, Chowers Y, Lavy A, Abramovitch D, Sternberg A, Leichtmann G, Reshef R, Odes S, Moshkovitz M, Bruck R, Eliakim R, Maoz E and Mittmann U. 19981022. Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group. : Gastroenterology.

Harvard

Bar-Meir S., Chowers Y., Lavy A., Abramovitch D., Sternberg A., Leichtmann G., Reshef R., Odes S., Moshkovitz M., Bruck R., Eliakim R., Maoz E. and Mittmann U. (19981022). Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group. : Gastroenterology.

MLA

Bar-Meir S, Chowers Y, Lavy A, Abramovitch D, Sternberg A, Leichtmann G, Reshef R, Odes S, Moshkovitz M, Bruck R, Eliakim R, Maoz E and Mittmann U. Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group. : Gastroenterology. 19981022.